• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    DaVita Releases Annual Community Care Report, Highlights Achievements in Corporate Citizenship

    5/20/25 9:05:00 AM ET
    $DVA
    Misc Health and Biotechnology Services
    Health Care
    Get the next $DVA alert in real time by email

    Captures key initiatives achieved in 2024, driving 2025 ESG goals

    DENVER, May 20, 2025 /PRNewswire/ -- Today, DaVita (NYSE:DVA) published its Community Care report, underpinning its long-standing commitment to corporate citizenship and highlighting strides made towards ambitious Environmental, Social and Governance (ESG) goals set to be achieved this year. Milestones and achievements reflect calendar year 2024.

    In 2021, DaVita announced broadened ESG goals and has since reported progress against its five strategic focus areas: Patient Care, Teammate Engagement, Environmental Stewardship, Healthy Communities and Leading with Integrity and Accountability.

    "This year, we're celebrating 25 years of patient care and progress made toward improving the health and vibrancy of the communities and people we serve," said Javier Rodriguez, chief executive officer for DaVita. "As we look ahead, I'm excited to build upon these community health achievements with our unmatched passion for enhancing and shaping the care experience for people around the world."

    The following are notable milestones detailed in the report:

    Patient Care

    DaVita cares for patients globally at every stage along the kidney care journey -- from upstream preventative care to home dialysis, acute hospital care and supporting transplantation.

    • More than 8,200 DaVita patients received a kidney transplant, the provider's highest number of annual transplants to date.
    • More than 40,000 individuals participated in a Kidney Smart® class, DaVita's award-winning kidney disease education program, now available in over 13 languages.
    • More than 15% of DaVita patients dialyzed in the comfort of their home.
    • DaVita continued to advance its value-based care program, DaVita Integrated Kidney Care (IKC), which provides integrated care management services to health plans and government programs for members and beneficiaries with kidney disease.
    • DaVita worked with national organizations to expand access to education and prevention resources for chronic conditions, including the YMCA and American Diabetes Association (ADA).

    Teammate Engagement

    Belonging is central to DaVita's culture, which prioritizes creating an environment that inspires teammates (employees) to make a difference every day. Supporting people to show up as their best selves at work equips the broader care community to deliver the best care experience possible to patients.

    • 84% of DaVita teammates reported they feel that they belong at DaVita.
    • Fortune, USA Today, Newsweek and more recognized DaVita as an employer of choice.
    • 2,400+ teammates are pursuing or have received their nursing degree, funded by DaVita, as part of its Bridge to Your Dreams program.
    • Teammates logged over 147,000 volunteerism hours, achieving DaVita's 5-year volunteerism goal one year ahead of schedule.

    Environmental Stewardship

    DaVita is committed to maintaining a strong foundation of environmental stewardship to help protect the environment by embedding sustainability practices in its business operations. The organization has made meaningful progress towards its 2025 goals.

    • 100% of DaVita's global operations are on track to be matched by renewable energy purchases by 2025 via virtual power purchase agreements, including two new agreements in Europe.
    • More than 75 million gallons of water were saved through water efficiency projects in 2024, achieving DaVita's 2025 goal of saving 240 million gallons since 2021.
    • DaVita was named to the Carbon Disclosure Project (CDP) "A List," receiving the highest possible score.

    Healthy Communities

    DaVita's commitment to community care extends beyond health care services to empowering underserved regions with critical resources and education.

    • The 2024 DaVita Health Tour provided thousands of community members across the country with free health screenings and education focused on kidney health.
    • Through support from the DaVita Giving Foundation, the Food is Medicine Coalition provided more than 100,000 medically tailored meals to people with food insecurity and medical nutrition needs, including individuals living with end-stage kidney disease.

    Leading with Integrity & Accountability

    DaVita's purpose is to deliver exceptional care and a positive experience to patients. A key driver of the provider's ability to deliver on that promise begins with a steady approach to compliance with policies, applicable laws and regulations and consistent behaviors.

    • 9 out of 10 members of DaVita's Board of Directors are independent under New York Stock Exchange rules.
    • 99.9% of DaVita teammates completed annual compliance training in 2024.

    To learn more about DaVita's vision for corporate citizenship or to download the full report, visit DaVita.com/CommunityCare.

    About DaVita Inc.

    DaVita (NYSE:DVA) is a health care provider focused on transforming care delivery to improve quality of life for patients globally. As a comprehensive kidney care provider, DaVita has been a leader in clinical quality and innovation for 25 years. DaVita cares for patients at every stage and setting along their kidney health journey—from slowing the progression of kidney disease to helping to support transplantation, from acute hospital care to dialysis at home. As of March 31, 2025, DaVita served approximately 282,000 patients at 3,173 outpatient dialysis centers, of which 2,661 centers were located in the United States and 512 centers were located in 13 other countries worldwide. DaVita has reduced hospitalizations, improved mortality, helped improve health access and worked collaboratively to propel the kidney care community to adopt a higher quality standard of care for all patients, everywhere. To learn more, visit DaVita.com/About.

    Forward-Looking Statement

    This press release contains or refers to certain forward-looking statements within the meaning of the federal securities laws including, among other things. Without limiting the foregoing, statements including the words "expect," "intend," "will," "may," "continue," "target," "goal," "endeavor" and similar expressions are intended to identify forward-looking statements. The Company bases its forward-looking statements on information available to it on the date of this presentation, and undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of changed circumstances, new information, future events or otherwise, except as may otherwise be required by law. Actual future events could also differ materially due to numerous factors that involve substantial known and unknown risks and uncertainties including, among other things, the risks and uncertainties set forth under "Risk Factors" and elsewhere in the Company's reports on Form 10-K and Form 10-Q and the other risks and uncertainties discussed in any subsequent reports that the Company files with the Securities and Exchange Commission from time to time.

    Media Contact:

    DaVita Newsroom

    [email protected]

    2024 Community Care

     

    DaVita Logo (PRNewsfoto/DaVita)

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/davita-releases-annual-community-care-report-highlights-achievements-in-corporate-citizenship-302459638.html

    SOURCE DaVita

    Get the next $DVA alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $DVA

    DatePrice TargetRatingAnalyst
    3/6/2024$133.00Equal Weight
    Barclays
    8/7/2023$100.00 → $142.00Neutral → Buy
    UBS
    11/1/2022$97.00 → $72.00Buy → Hold
    Deutsche Bank
    10/31/2022$117.00 → $74.00Buy → Neutral
    UBS
    8/19/2022$106.00 → $117.00Buy
    UBS
    6/21/2022$110.00 → $90.00Underperform
    BofA Securities
    1/5/2022$114.00 → $125.00Hold
    Truist Securities
    10/29/2021$113.00 → $111.00Sector Perform
    RBC Capital
    More analyst ratings

    $DVA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by DaVita Inc. (Amendment)

      SC 13G/A - DAVITA INC. (0000927066) (Subject)

      2/13/24 5:02:42 PM ET
      $DVA
      Misc Health and Biotechnology Services
      Health Care
    • SEC Form SC 13G/A filed by DaVita Inc. (Amendment)

      SC 13G/A - DAVITA INC. (0000927066) (Subject)

      2/9/22 3:43:35 PM ET
      $DVA
      Misc Health and Biotechnology Services
      Health Care
    • SEC Form SC 13D/A filed by DaVita Inc. (Amendment)

      SC 13D/A - DAVITA INC. (0000927066) (Subject)

      8/4/21 4:02:59 PM ET
      $DVA
      Misc Health and Biotechnology Services
      Health Care

    $DVA
    Financials

    Live finance-specific insights

    See more

    $DVA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • DaVita Inc. 1st Quarter 2025 Results

      DENVER, May 12, 2025 /PRNewswire/ -- DaVita Inc. (NYSE:DVA) announced financial and operating results for the quarter ended March 31, 2025. "Our strong first quarter performance demonstrates the stability and consistency of our operating model" said Javier Rodriguez, CEO of DaVita Inc. "We maintain a steadfast commitment to being the provider, employer and partner of choice and returning value to our shareholders." Financial and operating highlights for the quarter ended March 31, 2025: Consolidated revenues were $3.224 billion.Operating income was $439 million.Diluted earnings per share was $2.00.Operating cash flow was $180 million and free cash flow was $(45) million.Repurchased 3.7 milli

      5/12/25 4:05:00 PM ET
      $DVA
      Misc Health and Biotechnology Services
      Health Care
    • DaVita Inc. Schedules 1st Quarter 2025 Investor Conference Call

      DENVER, April 30, 2025 /PRNewswire/ -- DaVita Inc. (NYSE:DVA), announced today that it will hold its quarterly conference call to discuss first quarter results on Monday, May 12, 2025, at 5:00 p.m. Eastern Time. The company plans to release its results after market close the same day. This call is also being webcast and can be accessed at the DaVita IR web page. You can join this call as follows:  Monday, May 12, 2025Starting at 5:00 p.m. EDTWebcast can be accessed using this link Dial in number: 877-918-6630International dial in: 517-308-9042 When calling in, please provide the operator the password "Earnings" and provide your name and company affiliation. Investors unable to listen to the

      4/30/25 11:00:00 AM ET
      $DVA
      Misc Health and Biotechnology Services
      Health Care
    • DaVita Inc. 4th Quarter 2024 Results

      DENVER, Feb. 13, 2025 /PRNewswire/ -- DaVita Inc. (NYSE:DVA) announced financial and operating results for the quarter ended December 31, 2024. "Despite a year with unique hurdles, we finished strong in 2024, producing full year adjusted operating income and adjusted EPS in the top half of our guidance range," said Javier Rodriquez, CEO of DaVita Inc. "As we embark on 2025, when we will be celebrating the 25th anniversary of DaVita, we look forward to continuing our efforts to improve clinical outcomes, enhance quality of life for our patients and teammates, and be a force for positive change in the healthcare system." Financial and operating highlights for the quarter and year ended Decembe

      2/13/25 4:05:00 PM ET
      $DVA
      Misc Health and Biotechnology Services
      Health Care
    • Director Moore Gregory J. was granted 348 shares, increasing direct ownership by 6% to 6,451 units (SEC Form 4)

      4 - DAVITA INC. (0000927066) (Issuer)

      5/16/25 9:15:16 PM ET
      $DVA
      Misc Health and Biotechnology Services
      Health Care
    • Director Berg Charles was granted 348 shares, increasing direct ownership by 2% to 19,982 units (SEC Form 4)

      4 - DAVITA INC. (0000927066) (Issuer)

      5/16/25 9:15:04 PM ET
      $DVA
      Misc Health and Biotechnology Services
      Health Care
    • Director Yale Phyllis R was granted 348 shares, increasing direct ownership by 3% to 13,201 units (SEC Form 4)

      4 - DAVITA INC. (0000927066) (Issuer)

      5/16/25 9:14:55 PM ET
      $DVA
      Misc Health and Biotechnology Services
      Health Care

    $DVA
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • DaVita Releases Annual Community Care Report, Highlights Achievements in Corporate Citizenship

      Captures key initiatives achieved in 2024, driving 2025 ESG goals DENVER, May 20, 2025 /PRNewswire/ -- Today, DaVita (NYSE:DVA) published its Community Care report, underpinning its long-standing commitment to corporate citizenship and highlighting strides made towards ambitious Environmental, Social and Governance (ESG) goals set to be achieved this year. Milestones and achievements reflect calendar year 2024. In 2021, DaVita announced broadened ESG goals and has since reported progress against its five strategic focus areas: Patient Care, Teammate Engagement, Environmental Stewardship, Healthy Communities and Leading with Integrity and Accountability. "This year, we're celebrating 25 years

      5/20/25 9:05:00 AM ET
      $DVA
      Misc Health and Biotechnology Services
      Health Care
    • DaVita Inc. 1st Quarter 2025 Results

      DENVER, May 12, 2025 /PRNewswire/ -- DaVita Inc. (NYSE:DVA) announced financial and operating results for the quarter ended March 31, 2025. "Our strong first quarter performance demonstrates the stability and consistency of our operating model" said Javier Rodriguez, CEO of DaVita Inc. "We maintain a steadfast commitment to being the provider, employer and partner of choice and returning value to our shareholders." Financial and operating highlights for the quarter ended March 31, 2025: Consolidated revenues were $3.224 billion.Operating income was $439 million.Diluted earnings per share was $2.00.Operating cash flow was $180 million and free cash flow was $(45) million.Repurchased 3.7 milli

      5/12/25 4:05:00 PM ET
      $DVA
      Misc Health and Biotechnology Services
      Health Care
    • DaVita Inc. Schedules 1st Quarter 2025 Investor Conference Call

      DENVER, April 30, 2025 /PRNewswire/ -- DaVita Inc. (NYSE:DVA), announced today that it will hold its quarterly conference call to discuss first quarter results on Monday, May 12, 2025, at 5:00 p.m. Eastern Time. The company plans to release its results after market close the same day. This call is also being webcast and can be accessed at the DaVita IR web page. You can join this call as follows:  Monday, May 12, 2025Starting at 5:00 p.m. EDTWebcast can be accessed using this link Dial in number: 877-918-6630International dial in: 517-308-9042 When calling in, please provide the operator the password "Earnings" and provide your name and company affiliation. Investors unable to listen to the

      4/30/25 11:00:00 AM ET
      $DVA
      Misc Health and Biotechnology Services
      Health Care

    $DVA
    SEC Filings

    See more
    • DaVita Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

      8-K - DAVITA INC. (0000927066) (Filer)

      5/20/25 4:58:28 PM ET
      $DVA
      Misc Health and Biotechnology Services
      Health Care
    • DaVita Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

      8-K - DAVITA INC. (0000927066) (Filer)

      5/20/25 9:07:35 AM ET
      $DVA
      Misc Health and Biotechnology Services
      Health Care
    • SEC Form 10-Q filed by DaVita Inc.

      10-Q - DAVITA INC. (0000927066) (Filer)

      5/12/25 5:02:10 PM ET
      $DVA
      Misc Health and Biotechnology Services
      Health Care

    $DVA
    Leadership Updates

    Live Leadership Updates

    See more
    • DaVita Appoints Jessica Hergenreter as Chief People Officer

      DENVER, Oct. 17, 2024 /PRNewswire/ -- DaVita, a leading provider of kidney care services, today announced Jessica (Jess) Hergenreter as its new chief people officer (CPO). In this position, Hergenreter will oversee DaVita's People Services team, leading initiatives to engage and uplift DaVita's more than 70,000 teammates (employees) worldwide. Earlier this year, DaVita was named as a Top Workplace by USA Today and one of America's Most Loved Companies by Newsweek. "Our incredible teammates are the difference makers for the care we provide to patients," said Javier Rodriguez, C

      10/17/24 1:00:00 PM ET
      $DVA
      Misc Health and Biotechnology Services
      Health Care
    • DaVita Appoints David Maughan New Chief Operating Officer, Mike Staffieri Steps into Emeritus Role

      DENVER, Sept. 13, 2024 /PRNewswire/ -- DaVita, a leading provider of kidney care services, today announced that David Maughan will assume the role of chief operating officer. This appointment builds on Maughan's 18-year tenure at DaVita in a range of leadership roles. After a celebrated 11-year tenure as chief operating officer, Mike Staffieri will step into the role of chief operating officer emeritus. Both appointments are effective September 15, 2024. "It's an exciting time for DaVita! Dave's extensive experience in operations leadership coupled with his deep knowledge of DaVita's business positions him well to build upon our incredible foundation of operational excellence and lead our on

      9/13/24 8:00:00 AM ET
      $DVA
      Misc Health and Biotechnology Services
      Health Care
    • DaVita Appoints New Chief Information Officer

      Madhu Narasimhan named to leadership role to accelerate technology-based innovations at DaVita  DENVER, May 13, 2024 /PRNewswire/ -- DaVita, a leading provider of kidney care services, today announced that Madhu Narasimhan will assume the role of chief information officer (CIO), effective June 3, 2024. In this leadership position, Narasimhan will be responsible for accelerating the implementation of DaVita's industry-leading health technology platforms. She will oversee DaVita's technology innovation strategy, including enterprise priorities like Center Without Walls™ (CWOW®),

      5/13/24 9:00:00 AM ET
      $DVA
      Misc Health and Biotechnology Services
      Health Care

    $DVA
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Barclays initiated coverage on DaVita with a new price target

      Barclays initiated coverage of DaVita with a rating of Equal Weight and set a new price target of $133.00

      3/6/24 8:09:27 AM ET
      $DVA
      Misc Health and Biotechnology Services
      Health Care
    • DaVita upgraded by UBS with a new price target

      UBS upgraded DaVita from Neutral to Buy and set a new price target of $142.00 from $100.00 previously

      8/7/23 7:20:56 AM ET
      $DVA
      Misc Health and Biotechnology Services
      Health Care
    • DaVita downgraded by Deutsche Bank with a new price target

      Deutsche Bank downgraded DaVita from Buy to Hold and set a new price target of $72.00 from $97.00 previously

      11/1/22 9:18:39 AM ET
      $DVA
      Misc Health and Biotechnology Services
      Health Care